Pfizer beats earnings expectations and lifts guidance, as COVID-19 revenue outlook increases 73%

Shares of Pfizer Inc. PFE, +0.55% jumped 1.6% toward a near five-month high in premarket trading Tuesday, after the drug giant beat earnings expectations and raised its full-year outlook, as revenue expectations for its COVID-19 vaccine jumped 73%.